A new TB vaccine could be a game changer for India and South Africa

A modelling study shows M72/AS01E dose’s potential impact and value in the two high burden tuberculosis countries.

Matthew Quaife, The Conversation

 & 

Finn McQuaid, The Conversation

· Feb 10, 2022 · 07:30 pm